BioNTech to lead $2 bn mRNA-based oncology therapy market despite challenges: GlobalData EP News Bureau Aug 31, 2023 BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials, predominantly targeting solid tumors…
